Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Pathog ; 20(1): e1011914, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38166152

ABSTRACT

Chlamydia vaccine approaches aspire to induce Th1 cells for optimal protection, despite the fact that there is no direct evidence demonstrating Th1-mediated Chlamydia clearance from the female reproductive tract (FRT). We recently reported that T-bet-deficient mice can resolve primary Chlamydia infection normally, undermining the potentially protective role of Th1 cells in Chlamydia immunity. Here, we show that T-bet-deficient mice develop robust Th17 responses and that mice deficient in Th17 cells exhibit delayed bacterial clearance, demonstrating that Chlamydia-specific Th17 cells represent an underappreciated protective population. Additionally, Th2-deficient mice competently clear cervicovaginal infection. Furthermore, we show that sensing of IFN-γ by non-hematopoietic cells is essential for Chlamydia immunity, yet bacterial clearance in the FRT does not require IFN-γ secretion by CD4 T cells. Despite the fact that Th1 cells are not necessary for Chlamydia clearance, protective immunity to Chlamydia is still dependent on MHC class-II-restricted CD4 T cells and IL-12p40. Together, these data point to IL-12p40-dependent CD4 effector maturation as essential for Chlamydia immunity, and Th17 cells to a lesser extent, yet neither Th1 nor Th2 cell development is critical. Future Chlamydia vaccination efforts will be more effective if they focus on induction of this protective CD4 T cell population.


Subject(s)
Chlamydia Infections , Chlamydia muridarum , Animals , Female , Mice , CD4-Positive T-Lymphocytes , Chlamydia Infections/genetics , Chlamydia Infections/microbiology , Interleukin-12 Subunit p40 , Mice, Inbred C57BL , Th1 Cells , Th17 Cells , Th2 Cells
2.
Immunohorizons ; 6(2): 184-190, 2022 02 24.
Article in English | MEDLINE | ID: mdl-35210292

ABSTRACT

The presence of memory lymphocytes in nonlymphoid tissues reflects prior immunological experience and can provide nonspecific defense against infection. In this study, we used a mouse cohousing approach to examine the effect of prior immunological experience on Salmonella and Chlamydia infection. As expected, cohousing of "dirty mice" with specific pathogen-free laboratory mice increased the frequency of effector memory T cells in laboratory mice and enhanced protection against systemic Listeria infection. In contrast, the course of systemic infection with Salmonella and mucosal infection with Chlamydia was largely unaffected by cohousing, despite enhanced frequencies of memory T cells. Thus, cohousing of laboratory mice reliably increases the proportion of memory T cells in circulation, but can it have variable effects on pathogen clearance.


Subject(s)
Chlamydia Infections , Immunologic Memory , Animals , CD8-Positive T-Lymphocytes , Chlamydia Infections/microbiology , Memory T Cells , Mice , Mice, Inbred C57BL
3.
Proc Natl Acad Sci U S A ; 118(21)2021 05 25.
Article in English | MEDLINE | ID: mdl-34001624

ABSTRACT

Anatomical positioning of memory lymphocytes within barrier tissues accelerates secondary immune responses and is thought to be essential for protection at mucosal surfaces. However, it remains unclear whether resident memory in the female reproductive tract (FRT) is required for Chlamydial immunity. Here, we describe efficient generation of tissue-resident memory CD4 T cells and memory lymphocyte clusters within the FRT after vaginal infection with Chlamydia Despite robust establishment of localized memory lymphocytes within the FRT, naïve mice surgically joined to immune mice, or mice with only circulating immunity following intranasal immunization, were fully capable of resisting Chlamydia infection via the vaginal route. Blocking the rapid mobilization of circulating memory CD4 T cells to the FRT inhibited this protective response. These data demonstrate that secondary protection in the FRT can occur in the complete absence of tissue-resident immune cells. The ability to confer robust protection to barrier tissues via circulating immune memory provides an unexpected opportunity for vaccine development against infections of the FRT.


Subject(s)
Antibodies, Bacterial/biosynthesis , CD4-Positive T-Lymphocytes/immunology , Chlamydia Infections/prevention & control , Chlamydia muridarum/immunology , Genitalia, Female/immunology , Immunization/methods , Administration, Intranasal , Administration, Intravaginal , Animals , Antigens, Bacterial/administration & dosage , Bacterial Vaccines/administration & dosage , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/microbiology , Cell Movement/drug effects , Cell Movement/immunology , Chlamydia Infections/immunology , Chlamydia Infections/microbiology , Chlamydia muridarum/drug effects , Chlamydia muridarum/growth & development , Chlamydia muridarum/pathogenicity , Female , Genitalia, Female/drug effects , Genitalia, Female/microbiology , Immunity, Mucosal/drug effects , Immunologic Memory/drug effects , Mice , Parabiosis/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...